Suviray Injection
By Suviray
Rx
1 Solution for Injection in a Vial

Composition
Erenumab(70mg/ml)

Manufacturer - Novartis India Ltd
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Expires on or after
May, 2026

liver
Suviray Injection is considered safe for patients with liver disease based on the limited available data. It is believed that adjusting the dose of Suviray Injection may not be necessary for individuals with liver issues. It is crucial to consult with your doctor to ensure the safe and appropriate use of this medication.

kidney
Limited data indicates Suviray Injection is likely safe for patients with kidney disease. Dose adjustment may not be necessary. Always consult your doctor.

alcohol
Consult your doctor when consuming alcohol with Suviray Injection.

driving
When using Suviray Injection, typically driving ability is not impacted.

pregnancy
Suviray Injection may not be safe to use during pregnancy. Studies on animals have shown potential harm to the developing baby. Your doctor will evaluate the benefits versus risks before prescribing. Kindly consult your doctor.

breastfeeding
It is better to consult your doctor before using Suviray Injection during breastfeeding.
Habit Forming | No |
Chemical Class | Peptides |
Therapeutic Class | NEURO CNS |
Action Class | Monoclonal antibodies |
₹24899
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025